
2seventy bio Acquired by Bristol Myers Squibb
2seventy bio, Inc. announced a definitive merger agreement under which Bristol Myers Squibb (will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash transaction for a total equity value of approximately $286 …